药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Thiazinam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thiazinam.
Potassium cation
Fenyramidol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fenyramidol.
Potassium cation
Lofepramine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lofepramine.
Potassium cation
Oxypertine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Oxypertine.
Potassium cation
Acetylglycinamide chloral hydrate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acetylglycinamide chloral hydrate.
Potassium cation
Neocitrullamon
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Neocitrullamon.
Potassium cation
Melitracen
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Melitracen.
Potassium cation
Chlorproethazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chlorproethazine.
Potassium cation
Vinbarbital
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vinbarbital.
Potassium cation
Bromisoval
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromisoval.
Potassium cation
Pheneturide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pheneturide.
Potassium cation
Styramate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Styramate.
Potassium cation
Phenprobamate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Phenprobamate.
Potassium cation
Deanol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Deanol.
Potassium cation
Pinazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pinazepam.
Potassium cation
Pyrithyldione
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pyrithyldione.
Potassium cation
Tetrazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tetrazepam.
Potassium cation
Trichloroethylene
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Trichloroethylene.
Potassium cation
Febarbamate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Febarbamate.
Potassium cation
Atracurium
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Atracurium.